Our previous studies demonstrated that interleukin-1 alpha (IL-1 alpha
) and soluble factors secreted by polarized uterine luminal epithelial
cells (UEC) stimulate prostaglandin (PG) secretion by uterine stromal
cells (USC). The present studies were aimed at determining the mechan
ism by which these agonists stimulate PG secretion by USC. The complet
e inhibition of IL-1 alpha- and UEC-induced PGE(2) secretion by cycloh
eximide and actinomycin-D in the presence of a saturating concentratio
n of arachidonic acid indicated that IL-1 alpha and UEC act to a large
extent by inducing de novo expression of PG endoperoxide synthase (PG
HS). Western blot analysis of membrane fractions from USC showed a 2-
to 4-fold accumulation of the mitogen-inducible isoform of PGHS (PGHS-
2), but not the constitutively expressed enzyme (PGHS-1), within 3 h o
f treatment with IL-1 alpha, UEC-conditioned medium, or serum. Inhibit
ion of UEC-stimulated PGHS-2 expression by anti-IL-1 alpha indicated t
hat IL-1 alpha is one factor secreted by UEC responsible for the synth
esis of USC PGHS-2. Expression of PGHS-2, but not PGHS-1, was inhibite
d by dexamethasone. Dexamethasone also inhibited IL-1 alpha- and UEC-s
timulated PGE(2) secretion by USC. Immunohistochemical studies demonst
rated that PGHS-2 is localized to implantation sites in newly differen
tiating USC at the time of blastocyst attachment, indicating a potenti
al physiological role for PGHS-2 in early stages of mouse implantation
. In contrast, PGHS-1 was localized to UEC during this period. Collect
ively, these results indicate that enhanced PG secretion by USC in res
ponse to IL-1 alpha and soluble factors secreted by UEC is due to sele
ctive expression of PGHS-2. In addition, the expression of PGHS-2 by U
SC in vivo during the periimplantation period may support PG secretion
required during early stages of embryo implantation.